Skip to main content

Table 3 Association of Race-Gender Groups with Time until LDL Cholesterol Control in Cox Proportional Hazards Models Adjusted for Sequentially Added Sets of Variables

From: A Retrospective Cohort Study of the Potency of lipid-lowering therapy and Race-gender Differences in LDL cholesterol control

  Variables Added to Model
  Unadjusted Socio-
demographic
Clinical
Comorbidities
Health Care Primary Care Provider LDL Management
  Hazard Ratio [95% CI]
Race-gender Group       
   Black Women 0.61
[0.53-0.69]‡
0.65
[0.56-0.76]‡
0.63
[0.54-0.74]‡
0.64
[0.54-0.75]‡
0.63
[0.53-0.74]‡
0.66
[0.56-0.78]‡
   Black Men 0.75
[0.64-0.86]‡
0.78
[0.66-0.93]†
0.77
[0.65-0.91]†
0.79
[0.66-0.94]†
0.73
[0.63-0.86]†
0.82
[0.69-0.98]*
   White Women 0.72
[0.62-0.83]‡
0.75
[0.64-0.87]‡
0.74
[0.64-0.86]‡
0.75
[0.64-0.87]‡
0.78
[0.65-0.93]‡
0.75
[0.64-0.88]†
   White Men 1.0 1.0 1.0 1.0 1.0 1.0
  1. *P < 0.05
  2. † P ≤ 0.01
  3. ‡ P ≤ 0.001
  4. Demographics [i.e., age, neighborhood income]; clinical comorbidities [i.e., vascular disease, diabetes, renal insufficiency, unrelated comorbidities, smoking]; health care [i.e., insurance, number of annual visits; visit adherence; antihypertensive medications]; primary care provider [i.e. type, race, gender, workload]; LDL management [i.e., baseline LDL, LDL checks within 6 months, and lipid-lowering drug potency].